相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vemurafenib and ipilimumab: A promising combination? Results of a case series
Jessica C. Hassel et al.
ONCOIMMUNOLOGY (2016)
Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours
Sonya C. Tate et al.
BRITISH JOURNAL OF CANCER (2016)
Targeted Therapies Combined With Immune Checkpoint Therapy
Peter A. Prieto et al.
CANCER JOURNAL (2016)
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016
Claus Garbe et al.
EUROPEAN JOURNAL OF CANCER (2016)
Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilities
Sebastian Zahnreich et al.
FUTURE ONCOLOGY (2016)
Overall Survival and Durable Responses in Patients With BRAF V600-Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
Georgina V. Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells
Panshi Zhang et al.
PLOS ONE (2016)
BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma
Luca Paoluzzi et al.
CANCER MEDICINE (2016)
Effects of Intermediate-Conductance Ca2+-Activated K+ Channels on Human Endometrial Carcinoma Cells
Yingli Zhang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Ca2+-Activated IK K+ Channel Blockade Radiosensitizes Glioblastoma Cells
Benjamin Stegen et al.
MOLECULAR CANCER RESEARCH (2015)
The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells
Yu Liu et al.
JOURNAL OF CANCER (2015)
BH3-only proteins - possible proapoptotic triggers for melanoma therapy
Michael Ploetz et al.
EXPERIMENTAL DERMATOLOGY (2014)
Targeted Therapy Resistance Mechanisms and Therapeutic Implications in Melanoma
Guo Chen et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Involvement of superoxide and nitric oxide in BRAFV600E inhibitor PLX4032-induced growth inhibition of melanoma cells
Ling Yu et al.
INTEGRATIVE BIOLOGY (2014)
RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells
Anja Berger et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Systemic treatment for BRAF-mutant melanoma: where do we go next?
Alexander M. Menzies et al.
LANCET ONCOLOGY (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vemurafenib Potently Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in BRAFV600E Melanoma Cells
Daniela Beck et al.
SCIENCE SIGNALING (2013)
ROS-dependent phosphorylation of Bax by wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis
S-A Quast et al.
CELL DEATH & DISEASE (2013)
Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor
Paola Corazao-Rozas et al.
ONCOTARGET (2013)
General Sensitization of Melanoma Cells for TRAIL-Induced Apoptosis by the Potassium Channel Inhibitor TRAM-34 Depends on Release of SMAC
Sandra-Annika Quast et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
New caspase-independent but ROS-dependent apoptosis pathways are targeted in melanoma cells by an iron-containing cytosine analogue
Jeannine C. Franke et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Human Caspases: Activation, Specificity, and Regulation
Cristina Pop et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
KCa3.1: target and marker for cancer, autoimmune disorder and vascular inflammation?
Chuan-Chu Chou et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
Overcoming apoptosis deficiency of melanoma - Hope for new therapeutic approaches
Juergen Eberle et al.
DRUG RESISTANCE UPDATES (2007)
KCa3.1 Ca2+-Activated K+ channels regulate human airway smooth muscle proliferation
Malcolm C. Shepherd et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Dose-escalation study of ICA-17043 in patients with sickle cell disease
Kenneth I. Ataga et al.
PHARMACOTHERAPY (2006)
Analysis of apoptosis by propidium iodide staining and flow cytometry
Carlo Riccardi et al.
NATURE PROTOCOLS (2006)
Clinical relevance of ion channels for diagnosis and therapy of cancer
R Schönherr
JOURNAL OF MEMBRANE BIOLOGY (2005)
Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice
EP Reich et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants
J Eberle et al.
ONCOGENE (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
K+ channels as therapeutic drug targets
AD Wickenden
PHARMACOLOGY & THERAPEUTICS (2002)
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis
M Raisova et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1:: A potential immunosuppressant
H Wulff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
